

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.96646478 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 6.96646478 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.70851015 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 6.70851015 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.31597696 |
| 6 | glyoxylate metabolic process (GO:0046487) | 5.72536947 |
| 7 | indole-containing compound catabolic process (GO:0042436) | 5.66255047 |
| 8 | indolalkylamine catabolic process (GO:0046218) | 5.66255047 |
| 9 | tryptophan catabolic process (GO:0006569) | 5.66255047 |
| 10 | tryptophan metabolic process (GO:0006568) | 5.38785833 |
| 11 | kynurenine metabolic process (GO:0070189) | 5.37612471 |
| 12 | cysteine metabolic process (GO:0006534) | 5.37384720 |
| 13 | bile acid biosynthetic process (GO:0006699) | 5.20350373 |
| 14 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.18717719 |
| 15 | sulfur amino acid catabolic process (GO:0000098) | 5.11583665 |
| 16 | DNA deamination (GO:0045006) | 5.02185811 |
| 17 | urea cycle (GO:0000050) | 4.81804831 |
| 18 | urea metabolic process (GO:0019627) | 4.81804831 |
| 19 | complement activation, alternative pathway (GO:0006957) | 4.76570803 |
| 20 | response to pheromone (GO:0019236) | 4.70689058 |
| 21 | platelet dense granule organization (GO:0060155) | 4.67550382 |
| 22 | lysine catabolic process (GO:0006554) | 4.64172519 |
| 23 | lysine metabolic process (GO:0006553) | 4.64172519 |
| 24 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.62031751 |
| 25 | protein carboxylation (GO:0018214) | 4.62031751 |
| 26 | homocysteine metabolic process (GO:0050667) | 4.61290309 |
| 27 | aromatic amino acid family metabolic process (GO:0009072) | 4.60406383 |
| 28 | high-density lipoprotein particle remodeling (GO:0034375) | 4.59524692 |
| 29 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.59192592 |
| 30 | alpha-linolenic acid metabolic process (GO:0036109) | 4.57510154 |
| 31 | nitrogen cycle metabolic process (GO:0071941) | 4.53945891 |
| 32 | aldehyde catabolic process (GO:0046185) | 4.50470923 |
| 33 | serine family amino acid catabolic process (GO:0009071) | 4.50166915 |
| 34 | negative regulation of fibrinolysis (GO:0051918) | 4.40088733 |
| 35 | regulation of protein activation cascade (GO:2000257) | 4.38470756 |
| 36 | bile acid metabolic process (GO:0008206) | 4.37560235 |
| 37 | regulation of cholesterol esterification (GO:0010872) | 4.32442001 |
| 38 | tyrosine metabolic process (GO:0006570) | 4.32040942 |
| 39 | coenzyme catabolic process (GO:0009109) | 4.25192211 |
| 40 | regulation of fibrinolysis (GO:0051917) | 4.23071004 |
| 41 | alpha-amino acid catabolic process (GO:1901606) | 4.17865175 |
| 42 | regulation of triglyceride catabolic process (GO:0010896) | 4.14141184 |
| 43 | regulation of complement activation (GO:0030449) | 4.13390229 |
| 44 | amino-acid betaine metabolic process (GO:0006577) | 4.12708744 |
| 45 | cellular glucuronidation (GO:0052695) | 4.11890670 |
| 46 | protein complex biogenesis (GO:0070271) | 4.11501813 |
| 47 | respiratory chain complex IV assembly (GO:0008535) | 4.08925183 |
| 48 | urate metabolic process (GO:0046415) | 4.04194850 |
| 49 | cofactor catabolic process (GO:0051187) | 4.02973992 |
| 50 | plasma lipoprotein particle remodeling (GO:0034369) | 4.02876004 |
| 51 | protein-lipid complex remodeling (GO:0034368) | 4.02876004 |
| 52 | macromolecular complex remodeling (GO:0034367) | 4.02876004 |
| 53 | amine catabolic process (GO:0009310) | 4.01049139 |
| 54 | cellular biogenic amine catabolic process (GO:0042402) | 4.01049139 |
| 55 | indolalkylamine metabolic process (GO:0006586) | 4.00639822 |
| 56 | drug transmembrane transport (GO:0006855) | 3.99095094 |
| 57 | serine family amino acid metabolic process (GO:0009069) | 3.98704898 |
| 58 | reverse cholesterol transport (GO:0043691) | 3.97790347 |
| 59 | proteasome assembly (GO:0043248) | 3.95920798 |
| 60 | benzene-containing compound metabolic process (GO:0042537) | 3.94511868 |
| 61 | uronic acid metabolic process (GO:0006063) | 3.92594912 |
| 62 | glucuronate metabolic process (GO:0019585) | 3.92594912 |
| 63 | cellular amino acid catabolic process (GO:0009063) | 3.91527727 |
| 64 | plasma lipoprotein particle clearance (GO:0034381) | 3.88586248 |
| 65 | negative regulation of sterol transport (GO:0032372) | 3.87912902 |
| 66 | negative regulation of cholesterol transport (GO:0032375) | 3.87912902 |
| 67 | triglyceride homeostasis (GO:0070328) | 3.86305607 |
| 68 | acylglycerol homeostasis (GO:0055090) | 3.86305607 |
| 69 | serine family amino acid biosynthetic process (GO:0009070) | 3.85138667 |
| 70 | cellular ketone body metabolic process (GO:0046950) | 3.81410021 |
| 71 | glycine metabolic process (GO:0006544) | 3.81215168 |
| 72 | cytochrome complex assembly (GO:0017004) | 3.78981284 |
| 73 | phospholipid efflux (GO:0033700) | 3.78496985 |
| 74 | protein neddylation (GO:0045116) | 3.76612271 |
| 75 | cellular modified amino acid catabolic process (GO:0042219) | 3.75096434 |
| 76 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.73304743 |
| 77 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.71481034 |
| 78 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.68943196 |
| 79 | bile acid and bile salt transport (GO:0015721) | 3.68433685 |
| 80 | behavioral response to nicotine (GO:0035095) | 3.67551033 |
| 81 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.67420702 |
| 82 | 2-oxoglutarate metabolic process (GO:0006103) | 3.66417444 |
| 83 | cytidine metabolic process (GO:0046087) | 3.65110856 |
| 84 | cytidine catabolic process (GO:0006216) | 3.65110856 |
| 85 | cytidine deamination (GO:0009972) | 3.65110856 |
| 86 | ethanol oxidation (GO:0006069) | 3.63046851 |
| 87 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.62173123 |
| 88 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.62173123 |
| 89 | NADH dehydrogenase complex assembly (GO:0010257) | 3.62173123 |
| 90 | arginine metabolic process (GO:0006525) | 3.61751008 |
| 91 | short-chain fatty acid metabolic process (GO:0046459) | 3.59916130 |
| 92 | drug catabolic process (GO:0042737) | 3.59542314 |
| 93 | glutamate metabolic process (GO:0006536) | 3.57416471 |
| 94 | valine metabolic process (GO:0006573) | 3.57251777 |
| 95 | low-density lipoprotein particle remodeling (GO:0034374) | 3.55578535 |
| 96 | carboxylic acid catabolic process (GO:0046395) | 3.54732281 |
| 97 | organic acid catabolic process (GO:0016054) | 3.54732281 |
| 98 | cullin deneddylation (GO:0010388) | 3.54577448 |
| 99 | cholesterol efflux (GO:0033344) | 3.54410477 |
| 100 | DNA double-strand break processing (GO:0000729) | 3.53587794 |
| 101 | protein K6-linked ubiquitination (GO:0085020) | 3.53489169 |
| 102 | fibrinolysis (GO:0042730) | 3.52887397 |
| 103 | NAD biosynthetic process (GO:0009435) | 3.52872970 |
| 104 | acetyl-CoA metabolic process (GO:0006084) | 3.52370049 |
| 105 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 3.49177635 |
| 106 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.48069965 |
| 107 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.48069965 |
| 108 | imidazole-containing compound metabolic process (GO:0052803) | 3.46296135 |
| 109 | drug transport (GO:0015893) | 3.42889944 |
| 110 | fatty acid beta-oxidation (GO:0006635) | 3.42317737 |
| 111 | replication fork processing (GO:0031297) | 3.41728755 |
| 112 | aspartate family amino acid catabolic process (GO:0009068) | 3.40163492 |
| 113 | fatty acid oxidation (GO:0019395) | 3.39705322 |
| 114 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.36930426 |
| 115 | response to nitrosative stress (GO:0051409) | 3.36852285 |
| 116 | drug metabolic process (GO:0017144) | 3.36452028 |
| 117 | cholesterol homeostasis (GO:0042632) | 3.34318691 |
| 118 | lipid oxidation (GO:0034440) | 3.34189241 |
| 119 | L-fucose catabolic process (GO:0042355) | 3.33687514 |
| 120 | fucose catabolic process (GO:0019317) | 3.33687514 |
| 121 | L-fucose metabolic process (GO:0042354) | 3.33687514 |
| 122 | monocarboxylic acid catabolic process (GO:0072329) | 3.33402336 |
| 123 | flavonoid metabolic process (GO:0009812) | 3.30865191 |
| 124 | protein deneddylation (GO:0000338) | 3.30710041 |
| 125 | ketone body metabolic process (GO:1902224) | 3.29889565 |
| 126 | sterol homeostasis (GO:0055092) | 3.29172738 |
| 127 | blood coagulation, intrinsic pathway (GO:0007597) | 3.26571409 |
| 128 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.26373569 |
| 129 | fatty acid catabolic process (GO:0009062) | 3.25845569 |
| 130 | ATP synthesis coupled proton transport (GO:0015986) | 3.25257065 |
| 131 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.25257065 |
| 132 | plasma lipoprotein particle assembly (GO:0034377) | 3.23341484 |
| 133 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.19918567 |
| 134 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.05739195 |
| 135 | protein-cofactor linkage (GO:0018065) | 3.05053016 |
| 136 | keratinocyte development (GO:0003334) | 3.01514682 |
| 137 | regulation of meiosis I (GO:0060631) | 3.00576465 |
| 138 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.99805799 |
| 139 | electron transport chain (GO:0022900) | 2.98908323 |
| 140 | intraciliary transport (GO:0042073) | 2.98792267 |
| 141 | respiratory electron transport chain (GO:0022904) | 2.95778025 |
| 142 | protein localization to cilium (GO:0061512) | 2.95489470 |
| 143 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.89964394 |
| 144 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.89964394 |
| 145 | anterograde synaptic vesicle transport (GO:0048490) | 2.89447018 |
| 146 | mannosylation (GO:0097502) | 2.86288661 |
| 147 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.85443416 |
| 148 | cornea development in camera-type eye (GO:0061303) | 2.82733679 |
| 149 | adenosine metabolic process (GO:0046085) | 2.80783906 |
| 150 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.79901995 |
| 151 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 2.79561464 |
| 152 | protein polyglutamylation (GO:0018095) | 2.79495074 |
| 153 | cilium morphogenesis (GO:0060271) | 2.76529012 |
| 154 | axoneme assembly (GO:0035082) | 2.76525857 |
| 155 | piRNA metabolic process (GO:0034587) | 2.69233441 |
| 156 | regulation of hexokinase activity (GO:1903299) | 2.65480641 |
| 157 | regulation of glucokinase activity (GO:0033131) | 2.65480641 |
| 158 | GPI anchor metabolic process (GO:0006505) | 2.63046403 |
| 159 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.61293166 |
| 160 | recombinational repair (GO:0000725) | 2.60858693 |
| 161 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 2.60064001 |
| 162 | amino acid salvage (GO:0043102) | 2.59562391 |
| 163 | L-methionine salvage (GO:0071267) | 2.59562391 |
| 164 | L-methionine biosynthetic process (GO:0071265) | 2.59562391 |
| 165 | double-strand break repair via homologous recombination (GO:0000724) | 2.57832953 |
| 166 | C-terminal protein lipidation (GO:0006501) | 2.57659483 |
| 167 | S-adenosylmethionine metabolic process (GO:0046500) | 2.57235244 |
| 168 | chaperone-mediated protein transport (GO:0072321) | 2.55747968 |
| 169 | pseudouridine synthesis (GO:0001522) | 2.54583279 |
| 170 | branched-chain amino acid catabolic process (GO:0009083) | 2.53938707 |
| 171 | regulation of cilium movement (GO:0003352) | 2.53798383 |
| 172 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.52633218 |
| 173 | adaptation of signaling pathway (GO:0023058) | 2.52346779 |
| 174 | dopamine transport (GO:0015872) | 2.51121222 |
| 175 | protein prenylation (GO:0018342) | 2.50068866 |
| 176 | prenylation (GO:0097354) | 2.50068866 |
| 177 | synapsis (GO:0007129) | 2.50067094 |
| 178 | xenobiotic catabolic process (GO:0042178) | 2.49965704 |
| 179 | ubiquinone biosynthetic process (GO:0006744) | 2.48963210 |
| 180 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.48379636 |
| 181 | detection of light stimulus involved in visual perception (GO:0050908) | 2.48379636 |
| 182 | C-terminal protein amino acid modification (GO:0018410) | 2.47210057 |
| 183 | negative regulation of telomere maintenance (GO:0032205) | 2.46893371 |
| 184 | signal peptide processing (GO:0006465) | 2.46304916 |
| 185 | behavioral response to ethanol (GO:0048149) | 2.44357228 |
| 186 | retinal cone cell development (GO:0046549) | 2.43489197 |
| 187 | epithelial cilium movement (GO:0003351) | 2.42945589 |
| 188 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.42169026 |
| 189 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.42169026 |
| 190 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.42169026 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.17808168 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.24951329 |
| 3 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.10496546 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.50553031 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.39290711 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.84130679 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.32136207 |
| 8 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.73576411 |
| 9 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.21330173 |
| 10 | VDR_22108803_ChIP-Seq_LS180_Human | 3.04995067 |
| 11 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.97106572 |
| 12 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.94582051 |
| 13 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.84591032 |
| 14 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.79318891 |
| 15 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.69947367 |
| 16 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.61581314 |
| 17 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.44673527 |
| 18 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.40409429 |
| 19 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.35830860 |
| 20 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.35516989 |
| 21 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.34890366 |
| 22 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.32596694 |
| 23 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.30238440 |
| 24 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.21365574 |
| 25 | EWS_26573619_Chip-Seq_HEK293_Human | 2.17913175 |
| 26 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.12932008 |
| 27 | P300_19829295_ChIP-Seq_ESCs_Human | 2.11285584 |
| 28 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.11145412 |
| 29 | FUS_26573619_Chip-Seq_HEK293_Human | 2.06707033 |
| 30 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.06678042 |
| 31 | GATA1_22025678_ChIP-Seq_K562_Human | 2.05355826 |
| 32 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.2426183 |
| 33 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.99717889 |
| 34 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.96500269 |
| 35 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.90566575 |
| 36 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.87934646 |
| 37 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.83195558 |
| 38 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.82688535 |
| 39 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.82295751 |
| 40 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.78671483 |
| 41 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.78543524 |
| 42 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.77328985 |
| 43 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.76437260 |
| 44 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.75630116 |
| 45 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.70005222 |
| 46 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.69908914 |
| 47 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.67650692 |
| 48 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.65764642 |
| 49 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.64400563 |
| 50 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.63470610 |
| 51 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.61028849 |
| 52 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.57927778 |
| 53 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.56828512 |
| 54 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.55577767 |
| 55 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.55051884 |
| 56 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.55051884 |
| 57 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.54458866 |
| 58 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.53349270 |
| 59 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.52202791 |
| 60 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.51150479 |
| 61 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.50668911 |
| 62 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.50211448 |
| 63 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.50143919 |
| 64 | * CBP_20019798_ChIP-Seq_JUKART_Human | 1.48013133 |
| 65 | * IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.48013133 |
| 66 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.46506108 |
| 67 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.45847518 |
| 68 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.44356963 |
| 69 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.43510606 |
| 70 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.41447913 |
| 71 | AR_25329375_ChIP-Seq_VCAP_Human | 1.41070520 |
| 72 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.40874946 |
| 73 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.39719748 |
| 74 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.39340759 |
| 75 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.38284439 |
| 76 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.36611255 |
| 77 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.36091960 |
| 78 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.34354416 |
| 79 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.32123241 |
| 80 | * CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.30447353 |
| 81 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.29725932 |
| 82 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.29631720 |
| 83 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.29631720 |
| 84 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.28246027 |
| 85 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.26733830 |
| 86 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.26002906 |
| 87 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.23712786 |
| 88 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.23213772 |
| 89 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.23159423 |
| 90 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.23054415 |
| 91 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.22229586 |
| 92 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.21294069 |
| 93 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.20950603 |
| 94 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.20891793 |
| 95 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.18500558 |
| 96 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.17940079 |
| 97 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.16377861 |
| 98 | TCF4_23295773_ChIP-Seq_U87_Human | 1.16036337 |
| 99 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.16003516 |
| 100 | STAT3_23295773_ChIP-Seq_U87_Human | 1.15771068 |
| 101 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.15669172 |
| 102 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.15251815 |
| 103 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.14930093 |
| 104 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.14915000 |
| 105 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.14640256 |
| 106 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.12965994 |
| 107 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.11862277 |
| 108 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.09433551 |
| 109 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.09325274 |
| 110 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.08276634 |
| 111 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.08258564 |
| 112 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.07927023 |
| 113 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 1.06875304 |
| 114 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.06405100 |
| 115 | NCOR_22424771_ChIP-Seq_293T_Human | 1.05883556 |
| 116 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.05442004 |
| 117 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.05129938 |
| 118 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.04592895 |
| 119 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.04468442 |
| 120 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.03878153 |
| 121 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.03540519 |
| 122 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.03329107 |
| 123 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.03309028 |
| 124 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.02780941 |
| 125 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 1.02517163 |
| 126 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.02185107 |
| 127 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.01976044 |
| 128 | * RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.01944837 |
| 129 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.01448520 |
| 130 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.01344216 |
| 131 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.99203741 |
| 132 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.98682535 |
| 133 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.98602061 |
| 134 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.95617202 |
| 135 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.95130668 |
| 136 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.94481208 |
| 137 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.91829472 |
| 138 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.90400336 |
| 139 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.89488156 |
| 140 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.84920726 |
| 141 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.83122648 |
| 142 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.79692202 |
| 143 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.77402750 |
| 144 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.76802428 |
| 145 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.75798830 |
| 146 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.74774676 |
| 147 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.74774676 |
| 148 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.74230479 |
| 149 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.73601465 |
| 150 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.73536446 |
| 151 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.73312036 |
| 152 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.72479485 |
| 153 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.72341818 |
| 154 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.72190900 |
| 155 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.71511180 |
| 156 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.71283298 |
| 157 | * CEBPB_22108803_ChIP-Seq_LS180_Human | 0.70339942 |
| 158 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.70221048 |
| 159 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.68964574 |
| 160 | AR_20517297_ChIP-Seq_VCAP_Human | 0.68409108 |
| 161 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.68183070 |
| 162 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.66359321 |
| 163 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.66096713 |
| 164 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.65452627 |
| 165 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.65425250 |
| 166 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.64021021 |
| 167 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.62490035 |
| 168 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.61829822 |
| 169 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.61306199 |
| 170 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.60702254 |
| 171 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.60296566 |
| 172 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.60141465 |
| 173 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.59962536 |
| 174 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.59921005 |
| 175 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.59658171 |
| 176 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.59515228 |
| 177 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.59504886 |
| 178 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.58829036 |
| 179 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.57702128 |
| 180 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.57493051 |
| 181 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.56486942 |
| 182 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.55685973 |
| 183 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.55602934 |
| 184 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.55016824 |
| 185 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.54503161 |
| 186 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.54291657 |
| 187 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.53943588 |
| 188 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.53447241 |
| 189 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.53223413 |
| 190 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.52378357 |
| 191 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.51852361 |
| 192 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.51590988 |
| 193 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.51272904 |
| 194 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.50312994 |
| 195 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.49937412 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.06451574 |
| 2 | MP0005360_urolithiasis | 6.85505932 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.44103066 |
| 4 | MP0005365_abnormal_bile_salt | 5.30422846 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.39783265 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 3.73617126 |
| 7 | MP0003252_abnormal_bile_duct | 3.59320738 |
| 8 | MP0002837_dystrophic_cardiac_calcinosis | 3.33528917 |
| 9 | MP0005083_abnormal_biliary_tract | 3.29677160 |
| 10 | MP0002102_abnormal_ear_morphology | 3.11943152 |
| 11 | MP0003195_calcinosis | 3.03318774 |
| 12 | MP0000372_irregular_coat_pigmentation | 2.99666995 |
| 13 | MP0005332_abnormal_amino_acid | 2.97291319 |
| 14 | MP0010329_abnormal_lipoprotein_level | 2.92648451 |
| 15 | MP0009840_abnormal_foam_cell | 2.85743857 |
| 16 | MP0002138_abnormal_hepatobiliary_system | 2.71280019 |
| 17 | MP0006054_spinal_hemorrhage | 2.55274540 |
| 18 | MP0001666_abnormal_nutrient_absorption | 2.44156399 |
| 19 | MP0008877_abnormal_DNA_methylation | 2.41344744 |
| 20 | MP0005646_abnormal_pituitary_gland | 2.30058416 |
| 21 | MP0004019_abnormal_vitamin_homeostasis | 2.29090377 |
| 22 | MP0006072_abnormal_retinal_apoptosis | 2.25753068 |
| 23 | MP0005551_abnormal_eye_electrophysiolog | 2.23391676 |
| 24 | MP0003191_abnormal_cellular_cholesterol | 2.20864913 |
| 25 | MP0003186_abnormal_redox_activity | 2.11565266 |
| 26 | MP0005075_abnormal_melanosome_morpholog | 2.01890716 |
| 27 | MP0000609_abnormal_liver_physiology | 1.89419717 |
| 28 | MP0005253_abnormal_eye_physiology | 1.85313478 |
| 29 | MP0005319_abnormal_enzyme/_coenzyme | 1.85283578 |
| 30 | MP0002938_white_spotting | 1.85097511 |
| 31 | MP0006292_abnormal_olfactory_placode | 1.83831411 |
| 32 | MP0002118_abnormal_lipid_homeostasis | 1.81911443 |
| 33 | MP0009643_abnormal_urine_homeostasis | 1.76490344 |
| 34 | MP0001984_abnormal_olfaction | 1.76001346 |
| 35 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.72371171 |
| 36 | MP0001764_abnormal_homeostasis | 1.66008658 |
| 37 | MP0000569_abnormal_digit_pigmentation | 1.65400308 |
| 38 | MP0003718_maternal_effect | 1.65392537 |
| 39 | MP0000427_abnormal_hair_cycle | 1.63108537 |
| 40 | MP0001968_abnormal_touch/_nociception | 1.62970066 |
| 41 | MP0002638_abnormal_pupillary_reflex | 1.59277776 |
| 42 | MP0005174_abnormal_tail_pigmentation | 1.57976292 |
| 43 | MP0003880_abnormal_central_pattern | 1.57352697 |
| 44 | MP0002736_abnormal_nociception_after | 1.55885094 |
| 45 | MP0003787_abnormal_imprinting | 1.53761321 |
| 46 | MP0008872_abnormal_physiological_respon | 1.52867238 |
| 47 | MP0009046_muscle_twitch | 1.51702759 |
| 48 | MP0002234_abnormal_pharynx_morphology | 1.49621817 |
| 49 | MP0003950_abnormal_plasma_membrane | 1.49023226 |
| 50 | MP0005451_abnormal_body_composition | 1.48731900 |
| 51 | MP0001485_abnormal_pinna_reflex | 1.48460610 |
| 52 | MP0004147_increased_porphyrin_level | 1.47262323 |
| 53 | MP0010386_abnormal_urinary_bladder | 1.45786637 |
| 54 | MP0009745_abnormal_behavioral_response | 1.44866854 |
| 55 | MP0003136_yellow_coat_color | 1.44282711 |
| 56 | MP0000516_abnormal_urinary_system | 1.44186513 |
| 57 | MP0005367_renal/urinary_system_phenotyp | 1.44186513 |
| 58 | MP0008789_abnormal_olfactory_epithelium | 1.42696559 |
| 59 | MP0003786_premature_aging | 1.41956591 |
| 60 | MP0003724_increased_susceptibility_to | 1.41808627 |
| 61 | MP0003868_abnormal_feces_composition | 1.34463956 |
| 62 | MP0004142_abnormal_muscle_tone | 1.33697470 |
| 63 | MP0009764_decreased_sensitivity_to | 1.32728410 |
| 64 | MP0005636_abnormal_mineral_homeostasis | 1.32263644 |
| 65 | MP0005084_abnormal_gallbladder_morpholo | 1.29851969 |
| 66 | MP0000631_abnormal_neuroendocrine_gland | 1.29363369 |
| 67 | MP0008469_abnormal_protein_level | 1.28609051 |
| 68 | MP0002751_abnormal_autonomic_nervous | 1.28377344 |
| 69 | MP0001501_abnormal_sleep_pattern | 1.26047635 |
| 70 | MP0002876_abnormal_thyroid_physiology | 1.25905037 |
| 71 | MP0002090_abnormal_vision | 1.24456066 |
| 72 | MP0008058_abnormal_DNA_repair | 1.24346061 |
| 73 | MP0003436_decreased_susceptibility_to | 1.22463540 |
| 74 | MP0002272_abnormal_nervous_system | 1.22407641 |
| 75 | MP0005220_abnormal_exocrine_pancreas | 1.20687727 |
| 76 | MP0005645_abnormal_hypothalamus_physiol | 1.20545447 |
| 77 | MP0005058_abnormal_lysosome_morphology | 1.20141685 |
| 78 | MP0009697_abnormal_copulation | 1.19385450 |
| 79 | MP0001986_abnormal_taste_sensitivity | 1.18755713 |
| 80 | MP0005389_reproductive_system_phenotype | 1.18679245 |
| 81 | MP0003183_abnormal_peptide_metabolism | 1.18439028 |
| 82 | MP0003656_abnormal_erythrocyte_physiolo | 1.17867860 |
| 83 | MP0005408_hypopigmentation | 1.16317704 |
| 84 | MP0002095_abnormal_skin_pigmentation | 1.15918460 |
| 85 | MP0002653_abnormal_ependyma_morphology | 1.13682178 |
| 86 | MP0001756_abnormal_urination | 1.12787864 |
| 87 | MP0004215_abnormal_myocardial_fiber | 1.12347753 |
| 88 | MP0000598_abnormal_liver_morphology | 1.12132408 |
| 89 | MP0003646_muscle_fatigue | 1.08589814 |
| 90 | MP0002254_reproductive_system_inflammat | 1.08064529 |
| 91 | MP0004782_abnormal_surfactant_physiolog | 1.07497875 |
| 92 | MP0001905_abnormal_dopamine_level | 1.06523429 |
| 93 | MP0006276_abnormal_autonomic_nervous | 1.06520582 |
| 94 | MP0003011_delayed_dark_adaptation | 1.06065351 |
| 95 | MP0009763_increased_sensitivity_to | 1.05704689 |
| 96 | MP0000015_abnormal_ear_pigmentation | 1.03646326 |
| 97 | MP0001835_abnormal_antigen_presentation | 1.02755310 |
| 98 | MP0000604_amyloidosis | 1.02288803 |
| 99 | MP0002160_abnormal_reproductive_system | 1.00558360 |
| 100 | MP0001486_abnormal_startle_reflex | 1.00012769 |
| 101 | MP0002282_abnormal_trachea_morphology | 0.99984960 |
| 102 | MP0004043_abnormal_pH_regulation | 0.99875348 |
| 103 | MP0002136_abnormal_kidney_physiology | 0.99390258 |
| 104 | MP0003137_abnormal_impulse_conducting | 0.99297435 |
| 105 | MP0000647_abnormal_sebaceous_gland | 0.98632636 |
| 106 | MP0005671_abnormal_response_to | 0.98022831 |
| 107 | MP0004885_abnormal_endolymph | 0.97598972 |
| 108 | MP0008995_early_reproductive_senescence | 0.97535410 |
| 109 | MP0002163_abnormal_gland_morphology | 0.97522826 |
| 110 | MP0001529_abnormal_vocalization | 0.97438844 |
| 111 | MP0005410_abnormal_fertilization | 0.95682185 |
| 112 | MP0003121_genomic_imprinting | 0.95335825 |
| 113 | MP0006036_abnormal_mitochondrial_physio | 0.94669517 |
| 114 | MP0006082_CNS_inflammation | 0.94362872 |
| 115 | MP0009785_altered_susceptibility_to | 0.94285953 |
| 116 | MP0005195_abnormal_posterior_eye | 0.91420419 |
| 117 | MP0005379_endocrine/exocrine_gland_phen | 0.90586630 |
| 118 | MP0003283_abnormal_digestive_organ | 0.90478666 |
| 119 | MP0009642_abnormal_blood_homeostasis | 0.88763456 |
| 120 | MP0000685_abnormal_immune_system | 0.88376615 |
| 121 | MP0001324_abnormal_eye_pigmentation | 0.87391526 |
| 122 | MP0001929_abnormal_gametogenesis | 0.86716300 |
| 123 | MP0005670_abnormal_white_adipose | 0.85197438 |
| 124 | MP0005171_absent_coat_pigmentation | 0.85176067 |
| 125 | MP0008775_abnormal_heart_ventricle | 0.83505736 |
| 126 | MP0004133_heterotaxia | 0.82324842 |
| 127 | MP0005647_abnormal_sex_gland | 0.82156239 |
| 128 | MP0003705_abnormal_hypodermis_morpholog | 0.81030661 |
| 129 | MP0002557_abnormal_social/conspecific_i | 0.81028867 |
| 130 | MP0000653_abnormal_sex_gland | 0.80091055 |
| 131 | MP0001119_abnormal_female_reproductive | 0.79545235 |
| 132 | MP0005376_homeostasis/metabolism_phenot | 0.78749592 |
| 133 | MP0002277_abnormal_respiratory_mucosa | 0.78467408 |
| 134 | MP0009780_abnormal_chondrocyte_physiolo | 0.78252278 |
| 135 | MP0001853_heart_inflammation | 0.78144911 |
| 136 | MP0005025_abnormal_response_to | 0.77931068 |
| 137 | MP0002419_abnormal_innate_immunity | 0.77861698 |
| 138 | MP0002210_abnormal_sex_determination | 0.77817558 |
| 139 | MP0001970_abnormal_pain_threshold | 0.77110108 |
| 140 | MP0000639_abnormal_adrenal_gland | 0.77106056 |
| 141 | MP0005464_abnormal_platelet_physiology | 0.76161568 |
| 142 | MP0001845_abnormal_inflammatory_respons | 0.75615305 |
| 143 | MP0009765_abnormal_xenobiotic_induced | 0.73431275 |
| 144 | MP0003638_abnormal_response/metabolism_ | 0.65981749 |
| 145 | MP0002078_abnormal_glucose_homeostasis | 0.64780146 |
| 146 | MP0009379_abnormal_foot_pigmentation | 0.64679073 |
| 147 | MP0002928_abnormal_bile_duct | 0.63568972 |
| 148 | MP0003959_abnormal_lean_body | 0.63467992 |
| 149 | MP0010368_abnormal_lymphatic_system | 0.62419437 |
| 150 | MP0005334_abnormal_fat_pad | 0.62171419 |
| 151 | MP0005535_abnormal_body_temperature | 0.61926820 |
| 152 | MP0001661_extended_life_span | 0.61209195 |
| 153 | MP0002148_abnormal_hypersensitivity_rea | 0.59657585 |
| 154 | MP0002971_abnormal_brown_adipose | 0.59452723 |
| 155 | MP0001790_abnormal_immune_system | 0.59318655 |
| 156 | MP0005387_immune_system_phenotype | 0.59318655 |
| 157 | MP0002132_abnormal_respiratory_system | 0.57385617 |
| 158 | MP0001765_abnormal_ion_homeostasis | 0.56113191 |
| 159 | MP0004130_abnormal_muscle_cell | 0.55821181 |
| 160 | MP0005266_abnormal_metabolism | 0.54437292 |
| 161 | MP0003690_abnormal_glial_cell | 0.52744296 |
| 162 | MP0002166_altered_tumor_susceptibility | 0.52270070 |
| 163 | MP0005395_other_phenotype | 0.51937310 |
| 164 | MP0003075_altered_response_to | 0.50797714 |
| 165 | MP0001533_abnormal_skeleton_physiology | 0.50640939 |
| 166 | MP0005164_abnormal_response_to | 0.49964815 |
| 167 | MP0005166_decreased_susceptibility_to | 0.48691515 |
| 168 | MP0005000_abnormal_immune_tolerance | 0.48289131 |
| 169 | MP0008260_abnormal_autophagy | 0.47939033 |
| 170 | MP0002168_other_aberrant_phenotype | 0.47310186 |
| 171 | MP0000249_abnormal_blood_vessel | 0.46073241 |
| 172 | MP0000230_abnormal_systemic_arterial | 0.45272187 |
| 173 | MP0001800_abnormal_humoral_immune | 0.44651319 |
| 174 | MP0002135_abnormal_kidney_morphology | 0.44098496 |
| 175 | MP0002295_abnormal_pulmonary_circulatio | 0.43465251 |
| 176 | MP0008873_increased_physiological_sensi | 0.43155271 |
| 177 | MP0009384_cardiac_valve_regurgitation | 0.42958530 |
| 178 | MP0000538_abnormal_urinary_bladder | 0.42950967 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.51559273 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 5.71534001 |
| 3 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.45899780 |
| 4 | Deep venous thrombosis (HP:0002625) | 5.37190011 |
| 5 | Xanthomatosis (HP:0000991) | 5.18171172 |
| 6 | Prolonged partial thromboplastin time (HP:0003645) | 5.09119999 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 4.87183872 |
| 8 | Complement deficiency (HP:0004431) | 4.39239537 |
| 9 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.36230798 |
| 10 | Hyperlipoproteinemia (HP:0010980) | 4.18974275 |
| 11 | Hyperammonemia (HP:0001987) | 4.04875440 |
| 12 | Pancreatic cysts (HP:0001737) | 4.03196504 |
| 13 | Hyperglycinuria (HP:0003108) | 3.96485937 |
| 14 | Joint hemorrhage (HP:0005261) | 3.96153708 |
| 15 | True hermaphroditism (HP:0010459) | 3.89747481 |
| 16 | Acute necrotizing encephalopathy (HP:0006965) | 3.85382789 |
| 17 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.83953695 |
| 18 | Ketosis (HP:0001946) | 3.82617038 |
| 19 | Pancreatic fibrosis (HP:0100732) | 3.81696047 |
| 20 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.75781607 |
| 21 | Hypoglycemic coma (HP:0001325) | 3.73450314 |
| 22 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.70525293 |
| 23 | Abnormality of glycine metabolism (HP:0010895) | 3.70525293 |
| 24 | Molar tooth sign on MRI (HP:0002419) | 3.70397283 |
| 25 | Abnormality of midbrain morphology (HP:0002418) | 3.70397283 |
| 26 | Hyperglycinemia (HP:0002154) | 3.66212922 |
| 27 | Progressive macrocephaly (HP:0004481) | 3.63840679 |
| 28 | Fat malabsorption (HP:0002630) | 3.60452858 |
| 29 | Abnormality of the common coagulation pathway (HP:0010990) | 3.60060585 |
| 30 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.57629448 |
| 31 | Abnormality of methionine metabolism (HP:0010901) | 3.57583374 |
| 32 | Mitochondrial inheritance (HP:0001427) | 3.55295920 |
| 33 | Hypolipoproteinemia (HP:0010981) | 3.52081139 |
| 34 | Epidermoid cyst (HP:0200040) | 3.49069525 |
| 35 | Increased CSF lactate (HP:0002490) | 3.41403765 |
| 36 | Nephronophthisis (HP:0000090) | 3.38146854 |
| 37 | Abnormality of complement system (HP:0005339) | 3.37027510 |
| 38 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.31632908 |
| 39 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.29238386 |
| 40 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.26065238 |
| 41 | Gout (HP:0001997) | 3.23555128 |
| 42 | Congenital stationary night blindness (HP:0007642) | 3.21172602 |
| 43 | Delayed CNS myelination (HP:0002188) | 3.20761035 |
| 44 | Abnormality of nucleobase metabolism (HP:0010932) | 3.17033234 |
| 45 | 3-Methylglutaconic aciduria (HP:0003535) | 3.15389878 |
| 46 | Medial flaring of the eyebrow (HP:0010747) | 3.11790592 |
| 47 | Abnormality of purine metabolism (HP:0004352) | 3.09733397 |
| 48 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.07210660 |
| 49 | Systemic lupus erythematosus (HP:0002725) | 3.06531744 |
| 50 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.02085291 |
| 51 | Ketoacidosis (HP:0001993) | 3.00858556 |
| 52 | Hepatocellular necrosis (HP:0001404) | 2.97962296 |
| 53 | Dicarboxylic aciduria (HP:0003215) | 2.96157843 |
| 54 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.96157843 |
| 55 | Generalized aminoaciduria (HP:0002909) | 2.95793492 |
| 56 | Steatorrhea (HP:0002570) | 2.95317965 |
| 57 | Hypoalphalipoproteinemia (HP:0003233) | 2.95251559 |
| 58 | Abnormality of the intrinsic pathway (HP:0010989) | 2.94108547 |
| 59 | Hypothermia (HP:0002045) | 2.93291061 |
| 60 | Abnormality of the renal cortex (HP:0011035) | 2.93193321 |
| 61 | Conjugated hyperbilirubinemia (HP:0002908) | 2.91634878 |
| 62 | Abnormality of the renal medulla (HP:0100957) | 2.90461502 |
| 63 | Hyperbilirubinemia (HP:0002904) | 2.84019638 |
| 64 | Hypercholesterolemia (HP:0003124) | 2.82722871 |
| 65 | Cerebral edema (HP:0002181) | 2.82082115 |
| 66 | Lethargy (HP:0001254) | 2.80388580 |
| 67 | Proximal tubulopathy (HP:0000114) | 2.71638760 |
| 68 | Abnormality of serum amino acid levels (HP:0003112) | 2.67478033 |
| 69 | Metabolic acidosis (HP:0001942) | 2.63327243 |
| 70 | Hepatocellular carcinoma (HP:0001402) | 2.61348336 |
| 71 | Increased hepatocellular lipid droplets (HP:0006565) | 2.61259178 |
| 72 | Methylmalonic acidemia (HP:0002912) | 2.61157668 |
| 73 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 2.59088904 |
| 74 | Vascular calcification (HP:0004934) | 2.57266703 |
| 75 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.57042544 |
| 76 | Renal cortical cysts (HP:0000803) | 2.56202839 |
| 77 | Thyroiditis (HP:0100646) | 2.54798308 |
| 78 | Lipid accumulation in hepatocytes (HP:0006561) | 2.53329471 |
| 79 | Renal Fanconi syndrome (HP:0001994) | 2.51153826 |
| 80 | Myocardial infarction (HP:0001658) | 2.50522493 |
| 81 | Nausea (HP:0002018) | 2.45482628 |
| 82 | Alkalosis (HP:0001948) | 2.42989096 |
| 83 | Glycosuria (HP:0003076) | 2.42951481 |
| 84 | Abnormality of urine glucose concentration (HP:0011016) | 2.42951481 |
| 85 | Vomiting (HP:0002013) | 2.42578842 |
| 86 | Malnutrition (HP:0004395) | 2.40559694 |
| 87 | Sclerocornea (HP:0000647) | 2.37987558 |
| 88 | Hypoproteinemia (HP:0003075) | 2.37917599 |
| 89 | Methylmalonic aciduria (HP:0012120) | 2.37025193 |
| 90 | Optic disc pallor (HP:0000543) | 2.36181417 |
| 91 | Glomerulonephritis (HP:0000099) | 2.33846185 |
| 92 | Hydroxyprolinuria (HP:0003080) | 2.33507230 |
| 93 | Abnormality of proline metabolism (HP:0010907) | 2.33507230 |
| 94 | Abolished electroretinogram (ERG) (HP:0000550) | 2.32549654 |
| 95 | Congenital, generalized hypertrichosis (HP:0004540) | 2.31677602 |
| 96 | Hypoplasia of the fovea (HP:0007750) | 2.30311977 |
| 97 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.30311977 |
| 98 | Attenuation of retinal blood vessels (HP:0007843) | 2.29678209 |
| 99 | Cardiovascular calcification (HP:0011915) | 2.29151176 |
| 100 | Spontaneous abortion (HP:0005268) | 2.28334232 |
| 101 | Abnormality of the lumbar spine (HP:0100712) | 2.27996745 |
| 102 | Hyperuricemia (HP:0002149) | 2.26925724 |
| 103 | Increased purine levels (HP:0004368) | 2.26925724 |
| 104 | Increased serum lactate (HP:0002151) | 2.25158744 |
| 105 | Tubular atrophy (HP:0000092) | 2.25059318 |
| 106 | Congenital primary aphakia (HP:0007707) | 2.24011326 |
| 107 | Cystic liver disease (HP:0006706) | 2.23256603 |
| 108 | Spastic diplegia (HP:0001264) | 2.22215946 |
| 109 | Pancreatitis (HP:0001733) | 2.22133403 |
| 110 | Amyloidosis (HP:0011034) | 2.21598110 |
| 111 | Anencephaly (HP:0002323) | 2.20244447 |
| 112 | Gait imbalance (HP:0002141) | 2.20192059 |
| 113 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.16660261 |
| 114 | Protuberant abdomen (HP:0001538) | 2.16314532 |
| 115 | Decreased central vision (HP:0007663) | 2.15940277 |
| 116 | Irritability (HP:0000737) | 2.15932941 |
| 117 | Male pseudohermaphroditism (HP:0000037) | 2.14959242 |
| 118 | Acute encephalopathy (HP:0006846) | 2.13807589 |
| 119 | Nephrogenic diabetes insipidus (HP:0009806) | 2.13003351 |
| 120 | Polydipsia (HP:0001959) | 2.11602501 |
| 121 | Abnormal drinking behavior (HP:0030082) | 2.11602501 |
| 122 | Lactic acidosis (HP:0003128) | 2.10884869 |
| 123 | Hypoglycemic seizures (HP:0002173) | 2.09031102 |
| 124 | Vacuolated lymphocytes (HP:0001922) | 2.08858394 |
| 125 | Skin nodule (HP:0200036) | 2.08657941 |
| 126 | Abnormality of the fovea (HP:0000493) | 2.08633705 |
| 127 | Opisthotonus (HP:0002179) | 2.06208703 |
| 128 | Short tibia (HP:0005736) | 2.05096157 |
| 129 | Respiratory failure (HP:0002878) | 2.04210382 |
| 130 | Mucopolysacchariduria (HP:0008155) | 2.03639708 |
| 131 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.03639708 |
| 132 | Congenital hepatic fibrosis (HP:0002612) | 2.03543177 |
| 133 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.03519059 |
| 134 | Abnormality of macular pigmentation (HP:0008002) | 2.01750197 |
| 135 | Postaxial foot polydactyly (HP:0001830) | 2.01288556 |
| 136 | Hemorrhage of the eye (HP:0011885) | 2.01262743 |
| 137 | Furrowed tongue (HP:0000221) | 2.00679414 |
| 138 | Type II lissencephaly (HP:0007260) | 2.00155087 |
| 139 | Beaking of vertebral bodies (HP:0004568) | 1.98923956 |
| 140 | Intestinal atresia (HP:0011100) | 1.98419921 |
| 141 | Hyperventilation (HP:0002883) | 1.98347165 |
| 142 | Pendular nystagmus (HP:0012043) | 1.98211571 |
| 143 | Bile duct proliferation (HP:0001408) | 1.97759025 |
| 144 | Abnormal biliary tract physiology (HP:0012439) | 1.97759025 |
| 145 | Neonatal onset (HP:0003623) | 1.97393804 |
| 146 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.97169157 |
| 147 | Esophageal varix (HP:0002040) | 1.96613039 |
| 148 | Exertional dyspnea (HP:0002875) | 1.96385271 |
| 149 | Abnormal cartilage morphology (HP:0002763) | 1.96036019 |
| 150 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.95282775 |
| 151 | Gingival bleeding (HP:0000225) | 1.95213342 |
| 152 | Genital tract atresia (HP:0001827) | 1.93532750 |
| 153 | Late onset (HP:0003584) | 1.93523063 |
| 154 | Abnormality of iron homeostasis (HP:0011031) | 1.92576284 |
| 155 | Hepatic necrosis (HP:0002605) | 1.91182472 |
| 156 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.90630176 |
| 157 | Increased corneal curvature (HP:0100692) | 1.90284571 |
| 158 | Keratoconus (HP:0000563) | 1.90284571 |
| 159 | Chronic hepatic failure (HP:0100626) | 1.90274691 |
| 160 | Abnormal gallbladder morphology (HP:0012437) | 1.88825646 |
| 161 | Dysostosis multiplex (HP:0000943) | 1.88454517 |
| 162 | Mitral stenosis (HP:0001718) | 1.86856733 |
| 163 | J-shaped sella turcica (HP:0002680) | 1.86674793 |
| 164 | Pathologic fracture (HP:0002756) | 1.86298998 |
| 165 | Acanthocytosis (HP:0001927) | 1.85803963 |
| 166 | Menorrhagia (HP:0000132) | 1.85803330 |
| 167 | Abnormality of renal resorption (HP:0011038) | 1.85677335 |
| 168 | Thoracic kyphosis (HP:0002942) | 1.85652792 |
| 169 | Brushfield spots (HP:0001088) | 1.84947675 |
| 170 | Albinism (HP:0001022) | 1.83370223 |
| 171 | Type I transferrin isoform profile (HP:0003642) | 1.80637180 |
| 172 | Disproportionate short-trunk short stature (HP:0003521) | 1.79753319 |
| 173 | Polyuria (HP:0000103) | 1.78819387 |
| 174 | Postaxial hand polydactyly (HP:0001162) | 1.78199067 |
| 175 | Vaginal atresia (HP:0000148) | 1.77660530 |
| 176 | Colon cancer (HP:0003003) | 1.76606388 |
| 177 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.75862331 |
| 178 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.73515272 |
| 179 | Abnormality of alanine metabolism (HP:0010916) | 1.73515272 |
| 180 | Hyperalaninemia (HP:0003348) | 1.73515272 |
| 181 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.73236120 |
| 182 | Gaze-evoked nystagmus (HP:0000640) | 1.69204685 |
| 183 | Abnormality of vitamin B metabolism (HP:0004340) | 1.69172910 |
| 184 | Abnormality of B cell number (HP:0010975) | 1.68843112 |
| 185 | Optic nerve hypoplasia (HP:0000609) | 1.68661420 |
| 186 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.68178834 |
| 187 | Absent thumb (HP:0009777) | 1.68152216 |
| 188 | Preaxial hand polydactyly (HP:0001177) | 1.67387500 |
| 189 | Severe combined immunodeficiency (HP:0004430) | 1.67304829 |
| 190 | Type 2 muscle fiber atrophy (HP:0003554) | 1.66616038 |
| 191 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.65716601 |
| 192 | Abnormal glycosylation (HP:0012345) | 1.65250264 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.17168865 |
| 2 | ERN1 | 3.78527703 |
| 3 | NME2 | 3.44111966 |
| 4 | NUAK1 | 3.30902606 |
| 5 | TRIM28 | 3.30033290 |
| 6 | BMPR1B | 3.20029825 |
| 7 | FGFR4 | 2.98027865 |
| 8 | MAP4K2 | 2.95479659 |
| 9 | ADRBK2 | 2.47399845 |
| 10 | ACVR1B | 2.45288065 |
| 11 | MAP3K14 | 2.43990630 |
| 12 | IRAK3 | 2.23462541 |
| 13 | MST1R | 2.21349801 |
| 14 | INSRR | 2.20038127 |
| 15 | SIK1 | 2.19671210 |
| 16 | TYK2 | 2.14973868 |
| 17 | PBK | 2.14957216 |
| 18 | FLT3 | 2.09206356 |
| 19 | TBK1 | 2.08635261 |
| 20 | TAOK3 | 2.05165080 |
| 21 | WNK4 | 2.01815289 |
| 22 | VRK2 | 1.96538025 |
| 23 | ERBB3 | 1.94680102 |
| 24 | ZAK | 1.84845302 |
| 25 | ABL2 | 1.79174986 |
| 26 | PLK2 | 1.76221303 |
| 27 | ERBB4 | 1.67215336 |
| 28 | MAP4K1 | 1.60580072 |
| 29 | MKNK2 | 1.58973469 |
| 30 | WNK3 | 1.57731138 |
| 31 | BLK | 1.53045241 |
| 32 | IRAK4 | 1.48051349 |
| 33 | PIK3CG | 1.47933262 |
| 34 | MAPK11 | 1.41897289 |
| 35 | MAPK13 | 1.41088071 |
| 36 | KDR | 1.40555036 |
| 37 | MET | 1.39751776 |
| 38 | PIM2 | 1.39151770 |
| 39 | TLK1 | 1.37727239 |
| 40 | IKBKB | 1.37335773 |
| 41 | BCR | 1.37281426 |
| 42 | VRK1 | 1.36542324 |
| 43 | OXSR1 | 1.36160267 |
| 44 | IKBKE | 1.32647150 |
| 45 | CASK | 1.32067241 |
| 46 | EIF2AK1 | 1.31742722 |
| 47 | MAP3K12 | 1.26846107 |
| 48 | DAPK2 | 1.24096714 |
| 49 | NEK9 | 1.23873472 |
| 50 | TNIK | 1.23419506 |
| 51 | TXK | 1.11989885 |
| 52 | CSNK1G1 | 1.11397677 |
| 53 | JAK3 | 1.11198791 |
| 54 | EPHB1 | 1.10341776 |
| 55 | MUSK | 1.09251881 |
| 56 | ZAP70 | 1.09154592 |
| 57 | BUB1 | 1.08931922 |
| 58 | JAK2 | 1.08639692 |
| 59 | PLK3 | 1.08068117 |
| 60 | FRK | 1.06591652 |
| 61 | CSNK1G3 | 1.05911014 |
| 62 | PAK3 | 1.05373436 |
| 63 | CSNK1G2 | 1.03529276 |
| 64 | MYLK | 1.03242665 |
| 65 | MAP3K3 | 1.02388164 |
| 66 | TGFBR1 | 1.02349303 |
| 67 | TGFBR2 | 0.98859789 |
| 68 | PTK6 | 0.97796465 |
| 69 | PRKCE | 0.96757686 |
| 70 | TIE1 | 0.96697256 |
| 71 | CSK | 0.95975809 |
| 72 | JAK1 | 0.94083048 |
| 73 | STK16 | 0.91894424 |
| 74 | MKNK1 | 0.88607420 |
| 75 | CSNK1A1L | 0.87906488 |
| 76 | EPHB2 | 0.86991641 |
| 77 | KIT | 0.86341671 |
| 78 | TEC | 0.85476037 |
| 79 | MAPK15 | 0.85385256 |
| 80 | PLK4 | 0.83048928 |
| 81 | SIK3 | 0.83006698 |
| 82 | FGFR2 | 0.82085779 |
| 83 | BTK | 0.81116947 |
| 84 | EIF2AK3 | 0.78913191 |
| 85 | GSK3A | 0.78823368 |
| 86 | TAF1 | 0.78401913 |
| 87 | NTRK1 | 0.78071224 |
| 88 | PHKG1 | 0.77939758 |
| 89 | PHKG2 | 0.77939758 |
| 90 | ADRBK1 | 0.77573068 |
| 91 | CSF1R | 0.77426282 |
| 92 | GRK7 | 0.77342770 |
| 93 | DYRK1B | 0.75661270 |
| 94 | PKN2 | 0.74834390 |
| 95 | WEE1 | 0.73524404 |
| 96 | LRRK2 | 0.73307503 |
| 97 | STK24 | 0.72995343 |
| 98 | MAP2K2 | 0.71916578 |
| 99 | CHUK | 0.71211690 |
| 100 | TRIB3 | 0.70388355 |
| 101 | BRSK2 | 0.69207864 |
| 102 | PRKCI | 0.68676840 |
| 103 | MAP2K3 | 0.68648939 |
| 104 | FER | 0.66113036 |
| 105 | GRK6 | 0.65977351 |
| 106 | PRKAA2 | 0.65887387 |
| 107 | MAP3K4 | 0.65667684 |
| 108 | PRKCD | 0.65152554 |
| 109 | STK38L | 0.63974379 |
| 110 | MAP3K11 | 0.63784035 |
| 111 | DAPK3 | 0.63657313 |
| 112 | EPHA4 | 0.63413827 |
| 113 | DYRK2 | 0.61469002 |
| 114 | STK3 | 0.61318232 |
| 115 | PRKCQ | 0.61246984 |
| 116 | PIK3CA | 0.60866769 |
| 117 | EPHA3 | 0.59588108 |
| 118 | MAPK4 | 0.59519919 |
| 119 | MAPKAPK5 | 0.59332961 |
| 120 | PRKCG | 0.59004946 |
| 121 | CDK6 | 0.58218232 |
| 122 | GRK5 | 0.57276057 |
| 123 | LYN | 0.54442682 |
| 124 | PTK2B | 0.54124218 |
| 125 | PIM1 | 0.53997666 |
| 126 | NLK | 0.52701368 |
| 127 | NEK1 | 0.50620667 |
| 128 | SYK | 0.49985608 |
| 129 | IGF1R | 0.48553099 |
| 130 | AKT3 | 0.48158036 |
| 131 | CDK8 | 0.47983761 |
| 132 | LIMK1 | 0.47634435 |
| 133 | IRAK1 | 0.47434004 |
| 134 | PKN1 | 0.47234629 |
| 135 | PRKCZ | 0.45005132 |
| 136 | PRKACG | 0.44266569 |
| 137 | CCNB1 | 0.43733607 |
| 138 | PDK2 | 0.42668796 |
| 139 | CAMK2A | 0.42604636 |
| 140 | MAPKAPK3 | 0.41216376 |
| 141 | ROCK1 | 0.41064049 |
| 142 | ILK | 0.40112846 |
| 143 | PINK1 | 0.39817366 |
| 144 | EIF2AK2 | 0.39485853 |
| 145 | TRPM7 | 0.38698990 |
| 146 | LCK | 0.38264300 |
| 147 | CAMKK2 | 0.37623509 |
| 148 | GRK1 | 0.37497065 |
| 149 | MINK1 | 0.37428923 |
| 150 | DAPK1 | 0.37273091 |
| 151 | PLK1 | 0.37221560 |
| 152 | ERBB2 | 0.37159725 |
| 153 | ABL1 | 0.36940905 |
| 154 | PNCK | 0.36458992 |
| 155 | MAP2K7 | 0.35991366 |
| 156 | ITK | 0.35861787 |
| 157 | EGFR | 0.35303887 |
| 158 | CSNK1A1 | 0.35201348 |
| 159 | STK39 | 0.34977805 |
| 160 | BMPR2 | 0.34712865 |
| 161 | RPS6KA6 | 0.34029677 |
| 162 | NTRK3 | 0.33938735 |
| 163 | PRKACA | 0.33831189 |
| 164 | MST4 | 0.33500005 |
| 165 | MAP2K1 | 0.33483226 |
| 166 | ARAF | 0.31357871 |
| 167 | MARK3 | 0.30332917 |
| 168 | CAMK2G | 0.29675915 |
| 169 | CAMK1D | 0.29525543 |
| 170 | PTK2 | 0.27772556 |
| 171 | RPS6KA4 | 0.27579413 |
| 172 | PRKG2 | 0.27535430 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.98068010 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.37967756 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.25515291 |
| 4 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.67585531 |
| 5 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.60204961 |
| 6 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.56585918 |
| 7 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.55542030 |
| 8 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.55391290 |
| 9 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.50912954 |
| 10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.50167127 |
| 11 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.41901512 |
| 12 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.35824677 |
| 13 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.31544854 |
| 14 | Peroxisome_Homo sapiens_hsa04146 | 2.28863117 |
| 15 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.23747200 |
| 16 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.12107108 |
| 17 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.03477662 |
| 18 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.98501036 |
| 19 | Basal transcription factors_Homo sapiens_hsa03022 | 1.96535660 |
| 20 | Phototransduction_Homo sapiens_hsa04744 | 1.93550126 |
| 21 | Homologous recombination_Homo sapiens_hsa03440 | 1.92897139 |
| 22 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.91356831 |
| 23 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.87473660 |
| 24 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.86700699 |
| 25 | RNA polymerase_Homo sapiens_hsa03020 | 1.82543016 |
| 26 | Histidine metabolism_Homo sapiens_hsa00340 | 1.82457734 |
| 27 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.79342493 |
| 28 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.78209847 |
| 29 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.77788579 |
| 30 | Huntingtons disease_Homo sapiens_hsa05016 | 1.75085004 |
| 31 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.74431551 |
| 32 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.73857858 |
| 33 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.66427535 |
| 34 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.64572214 |
| 35 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.63427032 |
| 36 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.61989600 |
| 37 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.61418796 |
| 38 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.59606822 |
| 39 | Retinol metabolism_Homo sapiens_hsa00830 | 1.56262862 |
| 40 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.55141290 |
| 41 | RNA degradation_Homo sapiens_hsa03018 | 1.53157983 |
| 42 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.52670936 |
| 43 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.51551188 |
| 44 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.49959707 |
| 45 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.48500490 |
| 46 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.39848645 |
| 47 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.36897161 |
| 48 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.36052005 |
| 49 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.34344665 |
| 50 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.34263988 |
| 51 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.33333690 |
| 52 | Asthma_Homo sapiens_hsa05310 | 1.28052218 |
| 53 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.28014634 |
| 54 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.26789654 |
| 55 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.26668145 |
| 56 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.25972442 |
| 57 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.24663754 |
| 58 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.22666047 |
| 59 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.21902617 |
| 60 | Carbon metabolism_Homo sapiens_hsa01200 | 1.19548962 |
| 61 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.17127620 |
| 62 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.16715840 |
| 63 | Bile secretion_Homo sapiens_hsa04976 | 1.16691419 |
| 64 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.16068341 |
| 65 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.12006492 |
| 66 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.10525128 |
| 67 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.09566078 |
| 68 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.08781954 |
| 69 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.07798897 |
| 70 | Mismatch repair_Homo sapiens_hsa03430 | 1.07642568 |
| 71 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.06251390 |
| 72 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.04784777 |
| 73 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.04589575 |
| 74 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.04063625 |
| 75 | Sulfur relay system_Homo sapiens_hsa04122 | 1.01166936 |
| 76 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.99896587 |
| 77 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.99770654 |
| 78 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.97889660 |
| 79 | ABC transporters_Homo sapiens_hsa02010 | 0.96781581 |
| 80 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.93196483 |
| 81 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.90290317 |
| 82 | Purine metabolism_Homo sapiens_hsa00230 | 0.83188692 |
| 83 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.82989836 |
| 84 | Allograft rejection_Homo sapiens_hsa05330 | 0.82667252 |
| 85 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.78337196 |
| 86 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.77614671 |
| 87 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.76121673 |
| 88 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.71577158 |
| 89 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.71469338 |
| 90 | Mineral absorption_Homo sapiens_hsa04978 | 0.70582747 |
| 91 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.69261458 |
| 92 | Nicotine addiction_Homo sapiens_hsa05033 | 0.69062605 |
| 93 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.65093641 |
| 94 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.62652695 |
| 95 | Olfactory transduction_Homo sapiens_hsa04740 | 0.61825409 |
| 96 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.60701323 |
| 97 | Metabolic pathways_Homo sapiens_hsa01100 | 0.58526824 |
| 98 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.51820721 |
| 99 | Lysine degradation_Homo sapiens_hsa00310 | 0.51533083 |
| 100 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.49402739 |
| 101 | Circadian rhythm_Homo sapiens_hsa04710 | 0.47681721 |
| 102 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.43700358 |
| 103 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.43541901 |
| 104 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.42817441 |
| 105 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.42344823 |
| 106 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.41894778 |
| 107 | Taste transduction_Homo sapiens_hsa04742 | 0.40128579 |
| 108 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.39288839 |
| 109 | Insulin secretion_Homo sapiens_hsa04911 | 0.37141966 |
| 110 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.36200322 |
| 111 | Morphine addiction_Homo sapiens_hsa05032 | 0.35326845 |
| 112 | RNA transport_Homo sapiens_hsa03013 | 0.35053715 |
| 113 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.32833107 |
| 114 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.32460291 |
| 115 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.31001753 |
| 116 | Lysosome_Homo sapiens_hsa04142 | 0.25757639 |
| 117 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.25394603 |
| 118 | Galactose metabolism_Homo sapiens_hsa00052 | 0.24902127 |
| 119 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.24109961 |
| 120 | Prion diseases_Homo sapiens_hsa05020 | 0.23712371 |
| 121 | Protein export_Homo sapiens_hsa03060 | 0.23395204 |
| 122 | Other glycan degradation_Homo sapiens_hsa00511 | 0.21836553 |
| 123 | Parkinsons disease_Homo sapiens_hsa05012 | 0.18923476 |
| 124 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.18473156 |
| 125 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.15562845 |
| 126 | Legionellosis_Homo sapiens_hsa05134 | 0.13108048 |
| 127 | Insulin resistance_Homo sapiens_hsa04931 | 0.11862457 |
| 128 | Proteasome_Homo sapiens_hsa03050 | 0.11492672 |
| 129 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.10109705 |
| 130 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.09128938 |
| 131 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.08362780 |
| 132 | Pertussis_Homo sapiens_hsa05133 | 0.08204767 |
| 133 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.06156241 |
| 134 | Alzheimers disease_Homo sapiens_hsa05010 | 0.04287470 |
| 135 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.03257982 |
| 136 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.02982136 |
| 137 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.02834172 |
| 138 | Ribosome_Homo sapiens_hsa03010 | 0.01144368 |
| 139 | Malaria_Homo sapiens_hsa05144 | 0.00583062 |
| 140 | Rheumatoid arthritis_Homo sapiens_hsa05323 | -0.0244757 |
| 141 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.0159109 |
| 142 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | -0.0076178 |

